Largest pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Spyre Therapeutics has the lowest figure of the 52 pharmaceutical companies ranked by revenue, at ZAR 0, followed by Praxis Precision Medicines (ZAR 0) and Dianthus Therapeutics (ZAR 35.2M). Figures as of 18 Nov 2026, 22:02 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- Lowest
- Spyre TherapeuticsZAR 0
- Median
- ZAR 55.3B
- Combined market value
- ZAR 87.34T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Spyre TherapeuticsSYRE · Health Care | ZAR 0 | ZAR 166.4B | ZAR 1,751.71 | 8.15% up | 286% up | ||
| 2 | Praxis Precision MedicinesPRAX · Health Care | ZAR 0 | ZAR 147.3B | ZAR 5,269.11 | 0.04% up | 61% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | ZAR 35.2M | ZAR 81.6B | ZAR 1,449.91 | 3.45% down | 113% up | ||
| 4 | Roivant SciencesROIV · Health Care | ZAR 142.6M | ZAR 484.5B | ZAR 668.67 | 0.05% up | 90% up | ||
| 5 | Protagonist TherapeuticsPTGX · Health Care | ZAR 794.5M | ZAR 143.3B | ZAR 2,195.42 | 2.00% up | 46% up | ||
| 6 | CytokineticsCYTK · Health Care | ZAR 1.5B | ZAR 123.4B | ZAR 886.04 | 0.64% down | 20% down | ||
| 7 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 3.3B | ZAR 142.5B | ZAR 2,055.23 | 2.08% up | 13% up | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | ZAR 4.6B | ZAR 103.2B | ZAR 5,157.23 | 1.67% up | 43% up | ||
| 9 | Travere TherapeuticsTVTX · Health Care | ZAR 8.5B | ZAR 83.3B | ZAR 867.39 | 1.68% down | 44% up | ||
| 10 | BridgeBio PharmaBBIO · Health Care | ZAR 8.7B | ZAR 262.4B | ZAR 1,346.84 | 1.58% up | 17% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 9B | ZAR 104.2B | ZAR 1,596.84 | 0.59% up | 31% up | ||
| 12 | InsmedINSM · Health Care | ZAR 10.5B | ZAR 453.8B | ZAR 2,068.35 | 1.69% down | 40% down | ||
| 13 | TG TherapeuticsTGTX · Health Care | ZAR 10.6B | ZAR 172.5B | ZAR 1,141.56 | 5.44% up | 107% up | ||
| 14 | Axsome TherapeuticsAXSM · Health Care | ZAR 11B | ZAR 121.7B | ZAR 2,313.51 | 1.43% down | 7% down | ||
| 15 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 11.7B | ZAR 128.9B | ZAR 1,641.04 | 0.06% down | 126% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | ZAR 13.1B | ZAR 128.1B | ZAR 1,170.39 | 3.25% down | 8% down | ||
| 17 | Ascendis PharmaASND · Health Care | ZAR 13.8B | ZAR 306.1B | ZAR 4,667.25 | 0.32% down | 28% up | ||
| 18 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 14.3B | ZAR 105.2B | ZAR 744.29 | 0.28% up | 10% up | ||
| 19 | Ionis PharmaceuticalsIONS · Health Care | ZAR 16.3B | ZAR 78.8B | ZAR 472.89 | 1.59% up | 64% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 16.5B | ZAR 159.7B | ZAR 6,872.85 | 5.67% down | 24% down | ||
| 21 | Legend BiotechLEGN · Health Care | ZAR 17.8B | ZAR 54.4B | ZAR 280.56 | 0.87% up | 42% down | ||
| 22 | AlkermesALKS · Health Care | ZAR 25.5B | ZAR 135.9B | ZAR 808.87 | 3.08% up | 58% up | ||
| 23 | PTC TherapeuticsPTCT · Health Care | ZAR 29.9B | ZAR 86.9B | ZAR 1,039.87 | 0.22% down | 20% down | ||
| 24 | Royalty PharmaRPRX · Health Care | ZAR 41.1B | ZAR 681.7B | ZAR 1,185.59 | 0.01% down | 78% up | ||
| 25 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 52.1B | ZAR 131.6B | ZAR 377.76 | 3.60% up | 83% up | ||
| 26 | United TherapeuticsUTHR · Health Care | ZAR 54.9B | ZAR 424.5B | ZAR 9,967.78 | 1.16% down | 23% up | ||
| 27 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 55.6B | ZAR 205.4B | ZAR 1,060.59 | 4.99% up | 11% up | ||
| 28 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 61.7B | ZAR 215.6B | ZAR 258.63 | 1.28% up | 5% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 64.1B | ZAR 345.5B | ZAR 2,579.39 | 4.54% down | 66% down | ||
| 30 | GenmabGMAB · Health Care | ZAR 64.2B | ZAR 542.6B | ZAR 880.00 | 1.91% down | 70% up | ||
| 31 | Jazz PharmaceuticalsJAZZ · Health Care | ZAR 73.7B | ZAR 274.6B | ZAR 4,277.75 | 2.93% up | 37% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | ZAR 81.4B | ZAR 230.4B | ZAR 460.98 | 3.29% up | 20% up | ||
| 33 | BeOne MedicinesONC · Health Care | ZAR 92.2B | ZAR 795.9B | ZAR 6,968.15 | 2.34% down | 17% up | ||
| 34 | GrifolsGRFS · Health Care | ZAR 144.1B | ZAR 99.5B | ZAR 146.23 | 1.85% down | 1% up | ||
| 35 | ZoetisZTS · Health Care | ZAR 163.4B | ZAR 600.3B | ZAR 1,477.37 | 2.50% up | 29% down | ||
| 36 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 207.2B | ZAR 2.35T | ZAR 9,261.81 | 0.42% up | 27% up | ||
| 37 | ViatrisVTRS · Health Care | ZAR 246.9B | ZAR 401.4B | ZAR 350.13 | 0.83% down | 96% up | ||
| 38 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 247.6B | ZAR 1.69T | ZAR 16,324.58 | 1.28% down | 36% up | ||
| 39 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 298B | ZAR 850.7B | ZAR 729.10 | 0.92% down | 74% up | ||
| 40 | Takeda PharmaceuticalTAK · Health Care | ZAR 487.2B | ZAR 1.17T | ZAR 367.23 | 1.71% down | 54% up | ||
| 41 | GSKGSK · Health Care | ZAR 748.6B | ZAR 1.68T | ZAR 838.73 | 1.34% down | 6% up | ||
| 42 | Abbott LaboratoriesABT · Health Care | ZAR 765.3B | ZAR 3.12T | ZAR 1,803.85 | 0.22% down | 17% down | ||
| 43 | Novo NordiskNVO · Health Care | ZAR 791.8B | ZAR 3T | ZAR 680.76 | 3.12% down | 17% down | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | ZAR 832.1B | ZAR 2.1T | ZAR 1,028.30 | 2.92% down | 34% up | ||
| 45 | SanofiSNY · Health Care | ZAR 835.7B | ZAR 1.95T | ZAR 813.53 | 0.86% down | 4% down | ||
| 46 | NovartisNVS · Health Care | ZAR 941.5B | ZAR 5.06T | ZAR 2,679.70 | 2.46% down | 25% up | ||
| 47 | AstraZenecaAZN · Health Care | ZAR 1.01T | ZAR 4.79T | ZAR 3,086.29 | 1.93% down | 2% up | ||
| 48 | AbbVieABBV · Health Care | ZAR 1.06T | ZAR 8.73T | ZAR 4,937.96 | 2.33% down | 26% up | ||
| 49 | PfizerPFE · Health Care | ZAR 1.08T | ZAR 2.76T | ZAR 484.46 | 1.44% down | 14% up | ||
| 50 | Merck & CoMRK · Health Care | ZAR 1.12T | ZAR 5.86T | ZAR 2,378.77 | 3.90% down | 51% up | ||
| 51 | Eli LillyLLY · Health Care | ZAR 1.13T | ZAR 21.26T | ZAR 23,873.18 | 2.32% down | 35% up | ||
| 52 | Johnson & JohnsonJNJ · Health Care | ZAR 1.63T | ZAR 11.33T | ZAR 4,708.17 | 2.15% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2650 ZAR). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies have the lowest revenue?
Spyre Therapeutics (ZAR 0), Praxis Precision Medicines (ZAR 0) and Dianthus Therapeutics (ZAR 35.2M) have the lowest revenue of the 52 pharmaceutical companies ranked here as of 18 Nov 2026, 22:02 UTC.
How many pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 52 pharmaceutical companies ranked by revenue have a combined market value of ZAR 87.34T as of 18 Nov 2026, 22:02 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.